Shanghai, China

Xini Zhang

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Covidien LP, Alnova Pharmaceuticals, Ltd.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xini Zhang. Retrieved from https://idiyas.com/inventor/xini-zhang-6d5hcnn4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Xini Zhang

Introduction: Xini Zhang, a pioneering inventor hailing from Shanghai, China, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Zhang's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Zhang has worked with top research institutions and leading tech companies to bring his ideas to life. He has a proven track record of turning innovative concepts into practical applications.

Collaborations: Zhang has collaborated with renowned engineers, scientists, and designers from around the globe to push the boundaries of technology. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge products.

Conclusion: Xini Zhang's relentless pursuit of innovation and his passion for creating a better future through technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…